| Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised … DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ... The Lancet Oncology 20 (11), 1531-1543, 2019 | 430 | 2019 |
| Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non … AC Tree, P Ostler, H van der Voet, W Chu, A Loblaw, D Ford, S Tolan, ... The Lancet Oncology 23 (10), 1308-1320, 2022 | 137 | 2022 |
| The potential clinical benefit of respiratory gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC) R Muirhead, C Featherstone, A Duffton, K Moore, S McNee Radiotherapy and Oncology 95 (2), 172-177, 2010 | 52 | 2010 |
| Advanced practice: an ESTRO RTTC position paper A Duffton, L Devlin, Y Tsang, M Mast, M Leech Technical Innovations and Patient Support in Radiation Oncology 10, 16-19, 2019 | 37 | 2019 |
| An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients A Duffton, S Harrow, C Lamb, M McJury The British Journal of Radiology 89 (1062), 20150492, 2016 | 25 | 2016 |
| PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally … NJ Van As, D Brand, A Tree, PJ Ostler, W Chu, A Loblaw, D Ford, ... Journal of Clinical Oncology 37 (7_suppl), 1-1, 2019 | 23 | 2019 |
| The pivotal role of the therapeutic radiographer/radiation therapist in image-guided radiotherapy research and development A Duffton, W Li, E Forde Clinical Oncology 32 (12), 852-860, 2020 | 19 | 2020 |
| Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: a single centre feasibility study LK Hay, C Paterson, P McLoone, E Miguel-Chumacero, R Valentine, ... Technical Innovations & Patient Support in Radiation Oncology 14, 21-29, 2020 | 17 | 2020 |
| Meeting the challenges imposed by COVID-19: Guidance document by the ESTRO Radiation TherapisT Committee (RTTC) Y Tsang, A Duffton, M Leech, M Rossi, P Scherer Technical Innovations & Patient Support in Radiation Oncology 15, 6-10, 2020 | 16 | 2020 |
| Intensity-modulated radiotherapy for rectal cancer in the UK in 2020 CR Hanna, F Slevin, A Appelt, M Beavon, R Adams, C Arthur, M Beasley, ... Clinical Oncology 33 (4), 214-223, 2021 | 14 | 2021 |
| Diversity in radiation therapist/therapeutic radiographer (RTT) advanced practice (AP) roles delivering on the four domains A Duffton, K Moore, A Williamson Technical innovations & patient support in radiation oncology 17, 102-107, 2021 | 12 | 2021 |
| PACE Trial Investigators: Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACEB): acute toxicity findings from an … DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ... Lancet Oncol 20 (11), 1531-1543, 2019 | 12 | 2019 |
| Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features T Berger, DJ Noble, LEA Shelley, T McMullan, A Bates, S Thomas, ... Physics and Imaging in Radiation Oncology 24, 95-101, 2022 | 11 | 2022 |
| Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study C Paterson, S Allwood-Spiers, I McCrea, J Foster, M McJury, M Thomson, ... Clinical and Translational Radiation Oncology 2, 13-18, 2017 | 11 | 2017 |
| Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy L Devlin, D Dodds, A Sadozye, P McLoone, N MacLeod, C Lamb, ... The British journal of radiology 93 (1108), 20190789, 2020 | 10 | 2020 |
| Clinical commissioning of online seed matching protocol for prostate radiotherapy A Duffton, S McNee, R Muirhead, A Alhasso The British journal of radiology 85 (1020), e1273-e1281, 2012 | 10 | 2012 |
| PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant … DB Grose, CJ McKay, S Cooke, JS Graham, F Duthie, N Jamieson, ... Journal of Clinical Oncology 37 (15_suppl), TPS4166-TPS4166, 2019 | 8 | 2019 |
| Safety and feasibility of prostate stereotactic ablative radiotherapy using multimodality imaging and flattening filter free A Duffton, A Sadozye, L Devlin, N MacLeod, C Lamb, S Currie, ... The British Journal of Radiology 91 (1084), 20170625, 2018 | 7 | 2018 |
| Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy A Duffton, O Kemp, L Devlin, L Hay, P McLoone, C Paterson Technical Innovations & Patient Support in Radiation Oncology 19, 46-51, 2021 | 6 | 2021 |
| Potential for isotoxic re-irradiation stereotactic ablative body radiotherapy in locally recurrent rectal cancer M Robinson, S O'Cathail, A Duffton, K Aitken, R Muirhead Clinical Oncology 34 (9), 571-577, 2022 | 4 | 2022 |
